Word

DIMENSION THERAPEUTICS

Status

Dead

Status Code

606

Status Date

Monday, December 10, 2018

Serial Number

87449309

Mark Type

4000

Filing Date

Monday, May 15, 2017

Published for Opposition

Tuesday, March 13, 2018

Abandoned Date

Monday, December 10, 2018

Trademark Owner History

Dimension Therapeutics, Inc. - Owner At Publication

Classifications

1 Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, all for in-vivo laboratory use in gene therapy

5 Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, and fungal and viral diseases and disorders; pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction; Gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceutical preparations for the treatment of genetic diseases and disorders

42 Biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; diagnostics services in the field of equipment used for gene therapy design and delivery; gene therapy design and delivery development of biochemical assays

44 Providing medical services, namely, gene therapy medical services in the field of genetic diseases and disorders; providing medical services, namely, gene therapy medical services in the field of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; dispensing of pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction

"THERAPEUTICS"

Trademark Events

Dec 10, 2018

Abandonment Notice E-Mailed - No Use Statement Filed

Dec 10, 2018

Abandonment - No Use Statement Filed

May 8, 2018

Noa E-Mailed - Sou Required From Applicant

Mar 13, 2018

Official Gazette Publication Confirmation E-Mailed

Mar 13, 2018

Published For Opposition

Feb 21, 2018

Notification Of Notice Of Publication E-Mailed

Feb 7, 2018

Approved For Pub - Principal Register

Feb 7, 2018

Examiner's Amendment Entered

Feb 7, 2018

Notification Of Examiners Amendment E-Mailed

Feb 7, 2018

Examiners Amendment E-Mailed

Feb 7, 2018

Examiners Amendment -Written

Aug 14, 2017

Notification Of Non-Final Action E-Mailed

Aug 14, 2017

Non-Final Action E-Mailed

Aug 14, 2017

Non-Final Action Written

Aug 14, 2017

Assigned To Examiner

May 18, 2017

New Application Office Supplied Data Entered In Tram

May 18, 2017

New Application Entered In Tram